澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

新冠治疗股

973.374

-9.800-1.00%

涨家数：8

跌家数：6

平家数：19

市盈率：- -

高：979.857

开：978.636

低：970.285

收：983.174

成交量：2,575.48万

成交额：2.38亿

市值：2,414.65亿

流通市值：1,967.03亿

数据加载中...

总览新闻资讯

Dimerix年度亏损达2980万澳元，营收表现承压

Mesoblast Limited：预计短期内将持续面临重大亏损

基因标记公司：合并集团有望凭借精简成本基础与潜在加速增长受益

Woolworths预警：经济挑战持续，家庭预算压力不减

迪士尼Ooshies收藏品计划助力Woolworths前八周销售势头进一步增强

花旗和杰富瑞对澳大利亚科尔斯持乐观态度，因伍尔沃思的迪士尼营销活动带来的影响已有所缓解

Coles集团：以更整合的餐饮方案驱动财务绩效提升计划

Coles集团：启动多年计划，重塑酒类业务以应对消费趋势变迁

科尔斯集团：酒类业务销售势头在前八周相较2026财年第四季度有所增强

花旗、杰富瑞因业绩和前景向好上调澳大利亚安思尔的目标价

Ansell Limited预计2027财年按固定汇率计算销售额将实现增长，得益于2026财年完成的销量提升与定价措施

AnteoTech签署协议，共同开发、营销、制造及销售联合分离器产品

瑞思迈(RMD)股票8月19日盘中上涨3.43%：原因全解读

TradingKey中文

CSL Limited拟斥资约15亿美元扩大美国血浆生产版图

Mesoblast完成慢性腰痛关键性3期试验患者治疗，达成重大里程碑

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.etasphere.com/hans/stock/BK7501/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7501","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","market":"AU","secType":"PLATE","nameCN":"新冠治疗股","latestPrice":973.374,"timestamp":1787805780385,"preClose":983.1736,"halted":0,"volume":25754828,"delay":0,"changeRate":-0.009967,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-9.799561,"latestTime":"08-27 14:43:00 AEST","open":978.63605,"high":979.85693,"low":970.285,"amount":237571009,"amplitude":0.009736,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1787810400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787788800000,1787810400000]],"turnoverRate":0.001798,"increases":8,"decrements":6,"flats":18,"marketCap":241464816884.75,"floatMarketCap":196702725080.8047},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","high":979.85693,"amplitude":0.009736,"preClose":983.1736,"low":970.285,"latestPrice":973.374,"volume":25754828,"delay":0,"open":978.63605,"prevYearClose":900.1661,"prevWeekClose":948.336,"prevMonthClose":844.553,"prevQuarterClose":826.677,"fiveDayClose":961.774,"twentyDayClose":860.058,"sixtyDayClose":719.57,"secType":"PLATE","market":"AU","turnoverRate":0.001798,"marketCap":241464816884.75,"floatMarketCap":196702725080.8047,"timestamp":1787805780385,"nameCN":"新冠治疗股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7501\",,,,undefined,":{"bkCode":"BK7501","up":8,"down":6,"flat":19},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7501\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1192319982","title":"Dimerix年度亏损达2980万澳元，营收表现承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1192319982","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192319982?lang=zh_cn&edition=fundamental","pubTime":"2026-08-27 09:50","pubTimestamp":1787795440,"startTime":"0","endTime":"0","summary":"8月27日（路透社）——Dimerix Ltd（DXB.AX）最新财报显示，公司全年亏损额达2980万澳元。与此同时，该公司在报告期内的日常活动收入仅为700万澳元。这份业绩数据反映出公司当前面临的经营挑战，亏损规模与营收水平之间形成鲜明对比。市场投资者正密切关注该公司后续的财务策略与业务调整动向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","DXB.AU","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198020721","title":"Mesoblast Limited：预计短期内将持续面临重大亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=1198020721","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198020721?lang=zh_cn&edition=fundamental","pubTime":"2026-08-27 06:27","pubTimestamp":1787783223,"startTime":"0","endTime":"0","summary":"Mesoblast Limited近日发出预警，表明公司可能在未来可预见的一段时期内，继续承受显著的财务亏损。Mesoblast在研发上的持续投入，虽然从长远来看可能带来丰厚回报，但短期内却不可避免地加重了其财务负担。在当前生物科技板块波动加剧的背景下，Mesoblast的这一声明或将引发市场对其未来融资策略和现金流状况的更多关注。Mesoblast能否在亏损泥潭中找到突破口，市场正拭目以待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7067","MSB.AU","BK4139","MESO","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125560310","title":"基因标记公司：合并集团有望凭借精简成本基础与潜在加速增长受益","url":"https://stock-news.laohu8.com/highlight/detail?id=1125560310","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125560310?lang=zh_cn&edition=fundamental","pubTime":"2026-08-26 07:36","pubTimestamp":1787700997,"startTime":"0","endTime":"0","summary":"基因标记公司——合并后的集团预计将从精简的成本结构中获益，并可能迎来增长加速的契机。市场分析人士指出，成本基础的收窄不仅有助于提升盈利能力，更为潜在的扩张机遇创造了有利条件。值得注意的是，合并后实体的协同效应有望在中期内逐步显现，从而推动业绩增长轨迹向上修正。简而言之，这一变革性举措预示着集团将步入一个更加精简、高效且具备增长动能的新阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","GSS.AU","MAP.AU","BK7124","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171270849","title":"Woolworths预警：经济挑战持续，家庭预算压力不减","url":"https://stock-news.laohu8.com/highlight/detail?id=1171270849","media":"美股速递","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171270849?lang=zh_cn&edition=fundamental","pubTime":"2026-08-26 06:35","pubTimestamp":1787697310,"startTime":"0","endTime":"0","summary":"Woolworths集团表示，预计充满挑战的经济环境将继续存在，家庭预算仍将面临压力。\n这一判断来自公司对当前市场状况的评估。在消费者信心低迷、生活成本居高不下的背景下，零售巨头对前景持谨慎态度。\n该公司认为，短期内经济形势难以显著改善。家庭支出能力受限，消费行为趋于保守，这一趋势预计将持续。\nWoolworths的表态反映出零售商对宏观环境的担忧。随着通胀压力和利率水平维持高位，消费者可支配收入受到挤压，零售行业面临的需求阻力正在加大。\n对于未来走势，公司并未给出乐观预期，而是强调挑战的持续性。家庭预算承压的局面，短期内恐难以缓解。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7040","BK7501","WOW.AU","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109135125","title":"迪士尼Ooshies收藏品计划助力Woolworths前八周销售势头进一步增强","url":"https://stock-news.laohu8.com/highlight/detail?id=1109135125","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109135125?lang=zh_cn&edition=fundamental","pubTime":"2026-08-26 06:34","pubTimestamp":1787697266,"startTime":"0","endTime":"0","summary":"Woolworths集团——得益于迪士尼Ooshies收藏品计划的强力推动，其销售动能在前八周内得到进一步巩固与提升。这一合作项目不仅为零售商注入了新的活力，更在消费市场中引发了积极反响，使得整体业绩表现亮眼。随着该计划的持续推进，公司方面预计这一增长轨迹有望在短期内得以延续，为后续季度奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","WOW.AU","BK7040","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662757651","title":"花旗和杰富瑞对澳大利亚科尔斯持乐观态度，因伍尔沃思的迪士尼营销活动带来的影响已有所缓解","url":"https://stock-news.laohu8.com/highlight/detail?id=2662757651","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662757651?lang=zh_cn&edition=fundamental","pubTime":"2026-08-26 05:33","pubTimestamp":1787693605,"startTime":"0","endTime":"0","summary":"BUZZ-花旗和杰富瑞对澳大利亚科尔斯持乐观态度，因伍尔沃思的迪士尼营销活动带来的影响已有所缓解8月25日-** 花旗分析师预计，科尔斯（Coles）COL.AX用于资本管理的可用盈余资本约为15亿澳元（10.8亿美元）** 该券商将澳大利亚第二大食品零售商评级从“买入”下调至“中性”，称“利好消息已基本反映在股价中”** 花旗将该股目标价从每股23.00澳元上调至每股24.00澳元** 券商表示","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL4T44M1GF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4554","LU1732799900.SGD","LU0061475181.USD","LU1069347547.HKD","LU0208291251.USD","WOW.AU","LU0912757837.SGD","LU2357305700.SGD","LU1732800096.USD","BK7501","BK4561","BK4524","LU0310800379.SGD","DIS","LU0210533765.USD","BK7511","LU0314106906.USD","LU1267930573.SGD","LU1280957306.USD","SG9999015952.SGD","VOX","BK4534","LU0251142724.SGD","LU0320765489.SGD","LU0070217475.USD","IE0002270589.USD","LU1720051108.HKD","BK4585","BK4588","COL.AU","LU0795875169.SGD","WNDR","FCOM","LU0011850046.USD","BK4532","DISO","BK4598","LU1894683348.USD","LU0786609619.USD","IE00B19Z3581.USD","LU0640476718.USD","LU0029864427.USD","LU1720051017.SGD","LU0251131958.USD","SG9999015978.USD","LU0708994859.HKD","LU0795875086.SGD","LU1718418525.SGD","LU2347655156.SGD","LU2133065610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153154930","title":"Coles集团：以更整合的餐饮方案驱动财务绩效提升计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1153154930","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153154930?lang=zh_cn&edition=fundamental","pubTime":"2026-08-25 06:54","pubTimestamp":1787612053,"startTime":"0","endTime":"0","summary":"Coles集团正全力推进一项旨在提升财务表现的综合性计划，其核心在于打造一个更为融合的食品与饮料业务体系。Coles集团力求通过打破传统品类壁垒，构建一个无缝衔接的餐饮生态，从而在每一个触点都能向消费者传递一致的品牌价值。在竞争激烈的澳大利亚零售市场中，Coles集团此举显然意在构筑更高的竞争壁垒，以应对来自同业及新兴业态的多重挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7082","BK7501","BK7040","COL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125464014","title":"Coles集团：启动多年计划，重塑酒类业务以应对消费趋势变迁","url":"https://stock-news.laohu8.com/highlight/detail?id=1125464014","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125464014?lang=zh_cn&edition=fundamental","pubTime":"2026-08-25 06:54","pubTimestamp":1787612049,"startTime":"0","endTime":"0","summary":"Coles集团正着手实施一项为期多年的战略计划，旨在对其酒类业务进行重新定位，以灵活应对消费者偏好不断演变的现实挑战。这一举措反映出公司对市场动态的敏锐洞察，以及主动求变的坚定决心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7082","BK7040","COL.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120125990","title":"科尔斯集团：酒类业务销售势头在前八周相较2026财年第四季度有所增强","url":"https://stock-news.laohu8.com/highlight/detail?id=1120125990","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120125990?lang=zh_cn&edition=fundamental","pubTime":"2026-08-25 06:52","pubTimestamp":1787611928,"startTime":"0","endTime":"0","summary":"科尔斯集团有限公司在酒类业务方面传来消息——其销售轨迹在前八周内相较于2026财年第四季度呈现出明显的增强态势。这一进展，无疑为集团的整体表现注入了一剂强心针。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7040","BK7501","COL.AU","BK7082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662209544","title":"花旗、杰富瑞因业绩和前景向好上调澳大利亚安思尔的目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2662209544","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662209544?lang=zh_cn&edition=fundamental","pubTime":"2026-08-25 05:20","pubTimestamp":1787606443,"startTime":"0","endTime":"0","summary":"BUZZ-花旗、杰富瑞因业绩和前景向好上调澳大利亚安思尔的目标价8月24日-** 杰富瑞（Jefferies）的分析师上调了安思尔（Ansell，ANN.AX）的目标价，理由是该公司成功推进了各项计划和整合工作，同时正逐步实施提价措施** 该券商将目标价从38.20澳元/股上调至44.50澳元/股，并维持该股“买入”评级** 这家医用手套制造商周一表示（(link)），预计2027财年调整后每股收","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4T44L1HR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1162221912.USD","BK4534","LU1267930227.SGD","LU1244550221.USD","LU0980610538.SGD","LU0098860793.USD","LU0320765646.SGD","LU0648001328.SGD","IYF","LU1244550577.SGD","LU2462157665.USD","LU0310800965.SGD","BK4207","BK4588","LU0052756011.USD","LU0072461881.USD","LU1074936037.SGD","LU0203345920.USD","LU1144417596.USD","LU0170899867.USD","LU2417539215.USD","LU1668664300.SGD","LU0130102774.USD","IE00BSNM7G36.USD","LU0128525689.USD","BK4566","BK4585","LU0162691827.USD","TFNS","LU1244550494.USD","LU2456880835.USD","LU2360032135.SGD","LU2125154778.USD","BK7501","ANN.AU","FTXO","LU0130517989.USD","LU0106831901.USD","LU0477156953.USD","BK7126","LU2236285917.USD","BK4504","LU0203347892.USD","LU2125154935.USD","LU1201861249.SGD","LU1791807156.HKD","BK4559","LU1506573853.SGD","LU0314106906.USD","LU1366192091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100317420","title":"Ansell Limited预计2027财年按固定汇率计算销售额将实现增长，得益于2026财年完成的销量提升与定价措施","url":"https://stock-news.laohu8.com/highlight/detail?id=1100317420","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100317420?lang=zh_cn&edition=fundamental","pubTime":"2026-08-24 05:36","pubTimestamp":1787520969,"startTime":"0","endTime":"0","summary":"Ansell Limited预计，在2027财年，按固定汇率计算的销售额将实现增长，这一增长动力既源自于销量的提升，也得益于2026财年已落实的定价策略。\n该公司表示，2026财年期间所实施的定价行动，为下一财年的业绩表现奠定了坚实基础。与此同时，市场需求的回升也推动了产品销量的持续攀升，两方面因素共同作用下，公司对2027财年的营收前景持乐观态度。\n展望未来，管理层强调，这种增长态势不仅反映了公司对市场动态的敏锐把握，更凸显了其在成本管理与产品组合优化方面的持续努力。按固定汇率计，销售额的增长预期将为企业带来更为稳健的财务表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANN.AU","BK7501","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170784648","title":"AnteoTech签署协议，共同开发、营销、制造及销售联合分离器产品","url":"https://stock-news.laohu8.com/highlight/detail?id=1170784648","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170784648?lang=zh_cn&edition=fundamental","pubTime":"2026-08-20 07:30","pubTimestamp":1787182252,"startTime":"0","endTime":"0","summary":"AnteoTech宣布达成一项涵盖联合开发、市场营销、制造及销售环节的协议，该协议聚焦于联合分离器产品的全链条合作。此次合作涉及产品从研发到上市的关键环节，旨在整合各方资源，推动产品商业化进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7508","ADO.AU","BK7036","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660142238","title":"瑞思迈(RMD)股票8月19日盘中上涨3.43%：原因全解读","url":"https://stock-news.laohu8.com/highlight/detail?id=2660142238","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660142238?lang=zh_cn&edition=fundamental","pubTime":"2026-08-20 00:16","pubTimestamp":1787156188,"startTime":"0","endTime":"0","summary":"• 瑞思迈（ResMed）得益于资本配置里程碑及季度股息增加，展现出强劲的增长势头。\n• 剥离 MatrixCare 业务以及核心睡眠设备的强劲需求对积极的市场情绪构成支撑。\n• MACD 和威廉指标（Williams %R）等技术指标释放出买入信号。","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262118611-market-movers-rmd-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4504","LU0170899867.USD","BK7501","LU2008162690.USD","RMD","BK4548","BK7007","LGHT","LU2177674079.SGD","BK4082","RMD.AU","IE00B5TLWC47.USD","BK4588","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198570797","title":"CSL Limited拟斥资约15亿美元扩大美国血浆生产版图","url":"https://stock-news.laohu8.com/highlight/detail?id=1198570797","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198570797?lang=zh_cn&edition=fundamental","pubTime":"2026-08-18 06:02","pubTimestamp":1787004131,"startTime":"0","endTime":"0","summary":"CSL Limited宣布，计划投入约15亿美元，以进一步拓展其在美国的血浆制造业务布局。这一重大投资决策，彰显了该公司在全球血浆市场持续深耕的战略意图。据悉，这笔资金将用于扩大生产设施、提升产能，并强化其在美国本土的供应链体系。此举不仅有望巩固CSL在行业内的领先地位，更可能对全球血浆制品的供应格局产生深远影响。随着项目的逐步推进，CSL的产能优势或将进一步转化为市场竞争中的核心驱动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7067","CSL.AU","BK7511","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176396021","title":"Mesoblast完成慢性腰痛关键性3期试验患者治疗，达成重大里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1176396021","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176396021?lang=zh_cn&edition=fundamental","pubTime":"2026-08-17 08:36","pubTimestamp":1786926968,"startTime":"0","endTime":"0","summary":"Mesoblast（MESOBLAST LTD）在治疗慢性腰痛的关键性3期临床试验中，已顺利完成全部患者的治疗工作。这一成就标志着该公司在推进这一潜在疗法上迈出了决定性的一步。临床试验的完成，不仅为后续的数据分析铺平了道路，也极大地提振了市场对这款创新疗法的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7508","BK7067","MSB.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}